Agile Capital Markets is a fundraising and advisory boutique for high potential Life Sciences companies. Agile Capital Markets in a nutshell:- €315M+ secured, size of transactions from €5M to €60M- 1,000+ investors can be reached, WW spread- 90% of transactions with international syndications - For both Private & Public Equity- 90% of clients performed their next deal with us- Exclusively for Biotech, Medtech, Digital Health & Diagnostic companies Our services include, but are not limited to: Capital raising of series A to C+, Merger & Acquisitions (buy side, sell side), secondary offering, strategic advice, licensing deal negotiation, business model and business planning. We know how hard it is to bring innovation in healthcare, we recognize the hard-lifting work that is required to win. We, at Agile Capital Markets, are bringing our help and international network to secure the financial means for you to do just that.